188 related articles for article (PubMed ID: 8199858)
1. Methamphetamine-induced decrease in neural glucocorticoid receptors: relationship to monoamine levels.
Lowy MT; Novotney S
Brain Res; 1994 Feb; 638(1-2):175-81. PubMed ID: 8199858
[TBL] [Abstract][Full Text] [Related]
2. Reserpine-induced decrease in type I and II corticosteroid receptors in neuronal and lymphoid tissues of adrenalectomized rats.
Lowy MT
Neuroendocrinology; 1990 Feb; 51(2):190-6. PubMed ID: 2154717
[TBL] [Abstract][Full Text] [Related]
3. Effect of serotonin inhibition on glucocorticoid and mineralocorticoid expression in various brain structures.
Semont A; Fache M; Ouafik L; Hery M; Faudon M; Hery F
Neuroendocrinology; 1999 Feb; 69(2):121-8. PubMed ID: 9986925
[TBL] [Abstract][Full Text] [Related]
4. Short-term and long-term effects of p-chloroamphetamine on hippocampal serotonin and corticosteroid receptor levels.
Novotney S; Lowy MT
Brain Res; 1995 Jun; 684(1):19-25. PubMed ID: 7583200
[TBL] [Abstract][Full Text] [Related]
5. Methamphetamine self-administration and the effect of contingency on monoamine and metabolite tissue levels in the rat.
Brennan KA; Colussi-Mas J; Carati C; Lea RA; Fitzmaurice PS; Schenk S
Brain Res; 2010 Mar; 1317():137-46. PubMed ID: 19962371
[TBL] [Abstract][Full Text] [Related]
6. 5-hydroxy-3-ethylamino-2-oxindole is not formed in rat brain following a neurotoxic dose of methamphetamine: evidence that methamphetamine does not induce the hydroxyl radical-mediated oxidation of serotonin.
Yang Z; Wrona MZ; Dryhurst G
J Neurochem; 1997 May; 68(5):1929-41. PubMed ID: 9109519
[TBL] [Abstract][Full Text] [Related]
7. Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment.
Gluck MR; Moy LY; Jayatilleke E; Hogan KA; Manzino L; Sonsalla PK
J Neurochem; 2001 Oct; 79(1):152-60. PubMed ID: 11595767
[TBL] [Abstract][Full Text] [Related]
8. Kainic acid-induced decrease in hippocampal corticosteroid receptors.
Lowy MT
J Neurochem; 1992 Apr; 58(4):1561-8. PubMed ID: 1312577
[TBL] [Abstract][Full Text] [Related]
9. The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
Farfel GM; Vosmer GL; Seiden LS
Brain Res; 1992 Nov; 595(1):121-7. PubMed ID: 1361410
[TBL] [Abstract][Full Text] [Related]
10. The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.
Marek GJ; Vosmer G; Seiden LS
Brain Res; 1990 May; 516(1):1-7. PubMed ID: 2142010
[TBL] [Abstract][Full Text] [Related]
11. Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-L-tryptophan or fluoxetine.
Sémont A; Fache M; Héry F; Faudon M; Youssouf F; Héry M
J Neuroendocrinol; 2000 Aug; 12(8):736-44. PubMed ID: 10929085
[TBL] [Abstract][Full Text] [Related]
12. MK-801 antagonizes methamphetamine-induced decreases in hippocampal and striatal corticosteroid receptors.
Lowy MT
Brain Res; 1990 Nov; 533(2):348-52. PubMed ID: 2289150
[TBL] [Abstract][Full Text] [Related]
13. Sodium valproate induced alterations in monoamine levels in different regions of the rat brain.
Baf MH; Subhash MN; Lakshmana KM; Rao BS
Neurochem Int; 1994 Jan; 24(1):67-72. PubMed ID: 8130737
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo.
Sabol KE; Roach JT; Broom SL; Ferreira C; Preau MM
Brain Res; 2001 Feb; 892(1):122-9. PubMed ID: 11172757
[TBL] [Abstract][Full Text] [Related]
15. Rapid corticosteroid-dependent regulation of mineralocorticoid receptor protein expression in rat brain.
Kalman BA; Spencer RL
Endocrinology; 2002 Nov; 143(11):4184-95. PubMed ID: 12399411
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
Abekawa T
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
[TBL] [Abstract][Full Text] [Related]
17. Effects of adrenalectomy and corticosterone replacement on glucocorticoid receptor levels in rat brain tissue: a comparison between western blotting and receptor binding assays.
O'Donnell D; Francis D; Weaver S; Meaney MJ
Brain Res; 1995 Jul; 687(1-2):133-42. PubMed ID: 7583298
[TBL] [Abstract][Full Text] [Related]
18. Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stress.
Ahmad A; Rasheed N; Banu N; Palit G
Stress; 2010 Jul; 13(4):355-64. PubMed ID: 20536337
[TBL] [Abstract][Full Text] [Related]
19. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
Eyerman DJ; Yamamoto BK
J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
[TBL] [Abstract][Full Text] [Related]
20. Discrimination between changes in glucocorticoid receptor expression and activation in rat brain using western blot analysis.
Spencer RL; Kalman BA; Cotter CS; Deak T
Brain Res; 2000 Jun; 868(2):275-86. PubMed ID: 10854580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
